Does co-occurring social phobia interfere with alcoholism treatment adherence and relapse?

Department of Psychiatry and Forensic Medicine, Fundação Faculdade Federal de Ciências Médicas de Porto Alegre, Porto Alegre, RS, Brazil.
Journal of Substance Abuse Treatment (Impact Factor: 3.14). 01/2007; 31(4):403-9. DOI: 10.1016/j.jsat.2006.05.013
Source: PubMed


This study investigates the impact of social phobia on adherence to and outcomes 6 months following standard alcohol treatment and Alcoholics Anonymous (AA) group meetings among alcohol-dependent patients with and without social phobia. In a cohort study, 300 detoxified alcohol-dependent individuals in Porto Alegre, Brazil, were interviewed during, as well as 3 and 6 months after hospital detoxification. At both follow-up points, treatment adherence was low and relapse rates were high among patients with and without social phobia, and no significant differences were seen between the two groups of patients in relapse, adherence to AA, or adherence to psychotherapy. Findings from this sample suggest that although alcohol-dependent patients with social phobia showed a tendency for less adherence at AA and felt less integrated with their AA group, social phobia comorbidity was not a significant risk factor for alcohol use relapse or for nonadherence to AA or psychotherapy.

Download full-text


Available from: Dartiu X Silveira,
  • Source
    • "Gillesetal.,2006;Grantetal.,2005;Lewis&O'Neill,2000;Terlecki,Ecker,& Buckner,2014;Terraetal.,2006).Thecurrentstudyextendedthisbodyofresearchby determiningthatFPEwasstronglyrelatedtomoredrinking-relatedproblems.Notably, FPEwasrobustlyrelatedtodrinkingproblemsevenaftercontrollingforFNE,sex, typicalalcoholconsumption,andrecruitmentsite.Second,andconsistentwithpastwork findingsocialanxietytobeunrelatedtodrinkingquantityorfrequency(e.g.,Bruch, Heimberg,Harvey,&McCann,1992;Bruch,Rivet,Heimberg,&Levin,1997;Buckner, Eggleston,etal.,2006;Buckner&Heimberg,2010;O'Grady,Cullum,Armeli,& Tennan,2011),FPEwasnotsignificantlyrelatedtotypicalalcoholconsumption.Third, FPEwasrelatedtosocial,coping,andconformitydrinkingmotives.Takentogether,these datasuggestthatindividualswithelevatedFPEdonottypicallydrinkmoreoftenorin greaterquantitiesthantheirpeerswithlowerFPE;rather,theirmotivesfordrinking appeartobeassociatedwithgreaterproblems. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is strong empirical support that individuals with elevated social anxiety are at risk for alcohol-related impairment. Because social anxiety is a multi-faceted construct, it is important to consider which specific facets contribute to alcohol problem vulnerability. For example, although social anxiety has traditionally been conceptualized as a fear of negative evaluation (FNE), emerging data suggest that fear of positive evaluation (FPE) is also an important factor in pathological social anxiety. The current manuscript reports novel findings regarding FPE, alcohol use motives, and reported alcohol use problems. Participants included undergraduates from two American universities (n = 351) who completed a battery of measures assessing fears of evaluation, drinking motives, and alcohol usage related problems. FPE significantly predicted alcohol use problems, above and beyond FNE. Also, coping and conformity motives for drinking, but not social or enhancement motives, each uniquely mediated the relationship between FPE and alcohol use problems. FPE may be an important cognitive-affective vulnerability factor. With additional clinical research, FPE could serve as a meaningful therapeutic target in interventions designed to decrease problem drinking among highly socially anxious patients.
    Anxiety, stress, and coping 05/2015; DOI:10.1080/10615806.2015.1048509 · 1.55 Impact Factor
  • Source
    • "Currently, social anxiety in individuals seeking treatment for substance misuse social anxiety is poorly detected [45] and inadequately treated within alcohol and drug treatment settings [46]. Indeed, very few studies have attempted to address social anxiety in individuals presenting for substance use disorders [33]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Residential drug rehabilitation is often seen as a treatment of last resort for people with severe substance abuse issues. These clients present with more severe symptoms, and frequent psychiatric comorbidities relative to outpatients. Given the complex nature of this client group, a high proportion of clients seeking treatment often do not enter treatment, and of those who do, many exit prematurely. Given the highly social nature of residential drug rehabilitation services, it has been argued that social anxieties might decrease the likelihood of an individual entering treatment, or increase the likelihood of prematurely exiting treatment. The current paper reports on the protocol of a Randomised Control Trial which examined whether treatment of social anxiety prior to entry to treatment improves entry rates and retention in residential drug rehabilitation.Method/design: A Randomised Control Trial comparing a social skills treatment with a treatment as usual control group was employed. The social skills training program was based on the principles of Cognitive Behaviour Therapy, and was adapted from Ron Rapee's social skills training program. A permutated block randomisation procedure was utilised. Participants are followed up at the completion of the program (or baseline plus six weeks for controls) and at three months following entry into residential rehabilitation (or six months post-baseline for participants who do not enter treatment). The current study could potentially have implications for addressing social anxiety within residential drug treatment services in order to improve entry and retention in treatment. The results might suggest that the use of additional screening tools in intake assessments, a focus on coping with social anxieties in support groups for clients waiting to enter treatment, and greater awareness of social anxiety issues is warranted.Australian New Zealand clinical trials registry: Australian New Zealand Clinical Trials Registry (ACTRN) registration number: ACTRN12611000579998.
    BMC Psychiatry 02/2014; 14(1):43. DOI:10.1186/1471-244X-14-43 · 2.21 Impact Factor
  • Source
    • "These findings suggest that anxiety disorders, and social anxiety specifically, contribute to poorer treatment outcomes, increases in relapse risk, persistence of substance use disorders, and repeated treatment episodes (Kushner, Abrams, & Borchardt 2000; Oei & Loveday 1997). In contrast to these findings, several studies of patients in addiction treatment found no difference on relapse rates at follow-ups up to 2 years between patients who had social anxiety and related symptoms and controls (LaBounty, Hatsukami, Morgan, & Nelson 1992; Marquenie et al. 2006; Terra et al. 2006). Given that many of the predictors of MHG-related benefit stem from prescribed social interactions, it would seem that individuals with more social anxiety would derive less benefit from MHG participation relative to people with less social anxiety (Tonigan et al. 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is debate about whether dually diagnosed patients benefit from mutual-help groups (MHGs), partly because social anxiety may make participation problematic. We examined dually diagnosed patients' participation in MHGs and outcomes at 6, 12, and 24months post-treatment, and the extent to which social anxiety was associated with participation. We also examined whether MHG participation and social anxiety were related to outcomes, and whether social anxiety moderated associations between participation and outcomes. We found high rates of MHG participation. Among patients who attended at least one meeting, outcomes were positive. Social anxiety was not associated with levels of MHG participation, but more participation was associated with better outcomes. When social anxiety moderated associations between MHG participation and outcomes, patients with more social anxiety benefited more from participation. Treated dually diagnosed patients participate in, and benefit from, MHGs, and participation and benefits are comparable, or even strengthened, among more socially-anxious patients.
    Journal of substance abuse treatment 07/2012; 44(2). DOI:10.1016/j.jsat.2012.05.007 · 2.90 Impact Factor
Show more